The leading source for credible citizen reporting

Report Your News
Take the tour...
Mainstream News

Novartis to Boost China Presence

Source: Asian Wall Street Journal
Zurich : Switzerland | about 1 month ago  
0 0
Views: 15
Images
  • Hungary's PM Bajnai gets vaccinated against H1N1 flu in Budapest
    Hungary's PM Bajnai gets vaccinated against H1N1 flu in Budapest
    Source: Reuters
  • Syringes with influenza virus vaccine sitting on a tray
    Syringes with influenza virus vaccine sitting on a tray
    Source: AFP
See All Images
Hungary's PM Bajnai gets vaccinated against H1N1 flu in Budapest
This copy is for your personal, non-commercial use only...Novartis AG said Wednesday it plans to buy a majority stake in privately held Chinese vaccines maker Zhejiang Tianyuan for around $125 million, as the Swiss drug maker seeks to boost its presence in the world's third-largest vaccines market....
  • Print
  • Share:
  • Share
  • Digg
  • Reddit
  • Facebook
  • Stumbleupon
READ MORE: Novartis Swine-Flu Vaccine Approved, Novartis AG, Germany
More News From: Zurich : Switzerland

Related Allvoices Contributions

News Stories
 
  • Novartis Swine-Flu Vaccine Approved in Germany
    News Source: Asian Wall Street Journal | about 1 month ago
    This copy is for your personal, non-commercial use only...Swiss drug maker Novartis AG Thursday said it received regulatory approval to sell its cell-based swine flu vaccine in Germany, marking an important milestone in gaining acceptance for newer...
  • Novartis H1N1 vaccine approved
    News Source: The Economic Times | about 1 month ago
    Germany has approved Novartis AG's H1N1 swine flu vaccine Celtura, the Swiss drugmaker said on Thursday. Novartis, whose other H1N1 vaccine, Focetria, recently received backing in Switzerland, said it would continue to seek registration in other...
  • Novartis to Boost China Presence
    News Source: Asian Wall Street Journal | about 1 month ago
    This copy is for your personal, non-commercial use only...Novartis AG said Wednesday it plans to buy a majority stake in privately held Chinese vaccines maker Zhejiang Tianyuan for around $125 million, as the Swiss drug maker seeks to boost its...
  • Novartis To Buy 85% Of Chinese Vaccines Producer
    News Source: Fox News | about 1 month ago
    Novartis AG, the Basel health-care giant, said on Wednesday that it definitively agreed to acquire 85% of the closely held Chinese vaccines company Zhejiang Tianyuan Bio-Pharmaceutical Co. for about $125 million cash. The Chinese company produces...
Blogs
 >
  • Novartis Pays $125 Million for Tianyuan Stake - DealBook Blog ...
    Blog Source: dealbook.blogs.nytimes.com
    Novartis, the Swiss drug giant, said Wednesday it has agreed to cough up $125 million for an 85 percent stake in Chinese vaccine maker Zhejiang Tianyuan Bio-Pharmaceutical. ... The deal for Tianyuan, which also conducts research into various
  • Novartis Takes 85% Stake in Zhejiang Vaccine Maker
    Blog Source: www.thechinaperspective.com
    Novartis International AG, a multinational pharmaceutical company based in Switzerland, has purchased an 85% stake in Zhejiang Tianyuan Bio-Pharma, one of China's largest privately owned vaccine makers, to step up its grip on the ...
  • GenevaLunch » Blog Archive » Novartis buys into Chinese vaccine maker
    Blog Source: genevalunch.com
    Basel, Switzerland (GenevaLunch) - Swiss drugs maker, Novartis, has acquired 85 percent of Chinese vaccine maker Zhejiang Tianyuan Bio-Pharmaceutical Co. for $125 million, subject to government approval, the company announced 4 November ...
  • Novartis to expand its human vaccines presence in China through ...
    Blog Source: www.pharmiweb.com
    Tianyuan a privately-held vaccines company providing a competitive product portfolio and pipeline in China, where Novartis has a limited vaccines presence Tianyuan and Novartis to collaborate on building a vaccines industry leader ...
  • Novartis wants China as its No. 3 market - FiercePharma
    Blog Source: www.fiercepharma.com
    Novartis has upped the ante in China. Today, the Swiss drugmaker said it was buying an 85 percent chunk of the Chinese vaccines maker Zhejiang Tianyuan for $125 million. And that's just one-tenth of... Read more...
  • Novartis Expands China Vaccine Investments (NVS) : BioHealth Investor
    Blog Source: www.biohealthinvestor.com
    Novartis AG (NYSE: NVS) wants to get larger in teh realm of vaccines. In China for that matter. The Swiss drug giant has announced plans to buy an 85% majority stake in a privately held Chinese vaccine maker called Zhejiang Tianyuan. ...
More Related Blogs
Images
 >
 
More Related Images
Videos
 >
 
Post a Comment Comments: 0
Report Your News Got a similar story?
Add it to the network!

Or add related content to this report

News Stories | Blogs | Images | Videos | Comments

Cell phones Cell phones use report code: @4550065

Most Popular Reports
Most Viewed
Most Commented

Related Allvoices Reports

Site Links

Site Topics

Contributions

Help and Accounts

Administrative


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2009. All rights reserved.